+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Bladder Cancer Therapeutics - Market Analysis, Trends, and Forecasts

  • ID: 1206744
  • Report
  • 260 Pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Astrazeneca Plc
  • Celgene Corporation
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Glaxosmithkline Plc
  • Novartis International Ag
  • MORE
The Bladder Cancer Therapeutics market worldwide is projected to grow by US$89.9 Million, driven by a compounded growth of 4.8%. Transitional Cell Bladder Cancer, one of the segments analyzed and sized in this study, displays the potential to grow at over 5.6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$111.4 Million by the year 2025, Transitional Cell Bladder Cancer will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 3.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$3.2 Million to the region's size and clout in the next 5 to 6 years. Over US$2.6 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Transitional Cell Bladder Cancer will reach a market size of US$5.4 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 7.7% over the next couple of years and add approximately US$26.6 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • AstraZeneca plc
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Novartis International AG
  • Pfizer, Inc.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Astrazeneca Plc
  • Celgene Corporation
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Glaxosmithkline Plc
  • Novartis International Ag
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Bladder Cancer Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Bladder Cancer Therapeutics Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025

TABLE 2: Bladder Cancer Therapeutics Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017

TABLE 3: Bladder Cancer Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Transitional Cell Bladder Cancer (Type) World Market by Region/Country in US$ Thousand: 2018 to 2025

TABLE 5: Transitional Cell Bladder Cancer (Type) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017

TABLE 6: Transitional Cell Bladder Cancer (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Non Muscle Invasive/Superficial Bladder Cancer (Type) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025

TABLE 8: Non Muscle Invasive/Superficial Bladder Cancer (Type) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017

TABLE 9: Non Muscle Invasive/Superficial Bladder Cancer (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: Invasive Bladder Cancer (Type) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025

TABLE 11: Invasive Bladder Cancer (Type) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017

TABLE 12: Invasive Bladder Cancer (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Squamous Cell Bladder Cancer (Type) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025

TABLE 14: Squamous Cell Bladder Cancer (Type) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017

TABLE 15: Squamous Cell Bladder Cancer (Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 16: Adenocarcinoma of the Bladder (Type) World Market by Region/Country in US$ Thousand: 2018 to 2025

TABLE 17: Adenocarcinoma of the Bladder (Type) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017

TABLE 18: Adenocarcinoma of the Bladder (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 19: Rare Bladder Cancers (Type) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018 to 2025

TABLE 20: Rare Bladder Cancers (Type) Market Worldwide Historic Review by Region/Country in US$ Thousand: 2009 to 2017

TABLE 21: Rare Bladder Cancers (Type) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

TABLE 22: Surgery (Treatment) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2018 to 2025

TABLE 23: Surgery (Treatment) Global Historic Demand in US$ Thousand by Region/Country: 2009 to 2017

TABLE 24: Surgery (Treatment) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 25: Chemotherapy (Treatment) World Market by Region/Country in US$ Thousand: 2018 to 2025

TABLE 26: Chemotherapy (Treatment) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017

TABLE 27: Chemotherapy (Treatment) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 28: Immunotherapy (Treatment) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025

TABLE 29: Immunotherapy (Treatment) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017

TABLE 30: Immunotherapy (Treatment) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 31: Radiation Therapy (Treatment) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025

TABLE 32: Radiation Therapy (Treatment) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017

TABLE 33: Radiation Therapy (Treatment) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 34: Intravesical Therapy (Treatment) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025

TABLE 35: Intravesical Therapy (Treatment) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017

TABLE 36: Intravesical Therapy (Treatment) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Bladder Cancer Therapeutics Market Share (in %) by Company: 2019 & 2025

TABLE 37: United States Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Type: 2018 to 2025

TABLE 38: Bladder Cancer Therapeutics Market in the United States by Type: A Historic Review in US$ Thousand for 2009-2017

TABLE 39: United States Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 40: United States Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Treatment: 2018 to 2025

TABLE 41: Bladder Cancer Therapeutics Market in the United States by Treatment: A Historic Review in US$ Thousand for 2009-2017

TABLE 42: United States Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025

CANADA

TABLE 43: Canadian Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025

TABLE 44: Canadian Bladder Cancer Therapeutics Historic Market Review by Type in US$ Thousand: 2009-2017

TABLE 45: Bladder Cancer Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

TABLE 46: Canadian Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018 to 2025

TABLE 47: Canadian Bladder Cancer Therapeutics Historic Market Review by Treatment in US$ Thousand: 2009-2017

TABLE 48: Bladder Cancer Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025

JAPAN

TABLE 49: Japanese Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025

TABLE 50: Bladder Cancer Therapeutics Market in Japan: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017

TABLE 51: Japanese Bladder Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 52: Japanese Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Treatment for the Period 2018-2025

TABLE 53: Bladder Cancer Therapeutics Market in Japan: Historic Sales Analysis in US$ Thousand by Treatment for the Period 2009-2017

TABLE 54: Japanese Bladder Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025

CHINA

TABLE 55: Chinese Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025

TABLE 56: Bladder Cancer Therapeutics Historic Market Analysis in China in US$ Thousand by Type: 2009-2017

TABLE 57: Chinese Bladder Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 58: Chinese Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Treatment for the Period 2018-2025

TABLE 59: Bladder Cancer Therapeutics Historic Market Analysis in China in US$ Thousand by Treatment: 2009-2017

TABLE 60: Chinese Bladder Cancer Therapeutics Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Bladder Cancer Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 61: European Bladder Cancer Therapeutics Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025

TABLE 62: Bladder Cancer Therapeutics Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017

TABLE 63: European Bladder Cancer Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 64: European Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025

TABLE 65: Bladder Cancer Therapeutics Market in Europe in US$ Thousand by Type: A Historic Review for the Period 2009-2017

TABLE 66: European Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 67: European Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018-2025

TABLE 68: Bladder Cancer Therapeutics Market in Europe in US$ Thousand by Treatment: A Historic Review for the Period 2009-2017

TABLE 69: European Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025

FRANCE

TABLE 70: Bladder Cancer Therapeutics Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 71: French Bladder Cancer Therapeutics Historic Market Scenario in US$ Thousand by Type: 2009-2017

TABLE 72: French Bladder Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 73: Bladder Cancer Therapeutics Market in France by Treatment: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 74: French Bladder Cancer Therapeutics Historic Market Scenario in US$ Thousand by Treatment: 2009-2017

TABLE 75: French Bladder Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025

GERMANY

TABLE 76: Bladder Cancer Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025

TABLE 77: German Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Type: 2009-2017

TABLE 78: German Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 79: Bladder Cancer Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025

TABLE 80: German Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Treatment: 2009-2017

TABLE 81: German Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025

ITALY

TABLE 82: Italian Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025

TABLE 83: Bladder Cancer Therapeutics Historic Market Analysis in Italy in US$ Thousand by Type: 2009-2017

TABLE 84: Italian Bladder Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 85: Italian Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Treatment for the Period 2018-2025

TABLE 86: Bladder Cancer Therapeutics Historic Market Analysis in Italy in US$ Thousand by Treatment: 2009-2017

TABLE 87: Italian Bladder Cancer Therapeutics Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 88: United Kingdom Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025

TABLE 89: Bladder Cancer Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017

TABLE 90: United Kingdom Bladder Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 91: United Kingdom Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Treatment for the Period 2018-2025

TABLE 92: Bladder Cancer Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Treatment for the Period 2009-2017

TABLE 93: United Kingdom Bladder Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025

SPAIN

TABLE 94: Spanish Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025

TABLE 95: Spanish Bladder Cancer Therapeutics Historic Market Review by Type in US$ Thousand: 2009-2017

TABLE 96: Bladder Cancer Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

TABLE 97: Spanish Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018 to 2025

TABLE 98: Spanish Bladder Cancer Therapeutics Historic Market Review by Treatment in US$ Thousand: 2009-2017

TABLE 99: Bladder Cancer Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025

RUSSIA

TABLE 100: Russian Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Type: 2018 to 2025

TABLE 101: Bladder Cancer Therapeutics Market in Russia by Type: A Historic Review in US$ Thousand for 2009-2017

TABLE 102: Russian Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 103: Russian Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Treatment: 2018 to 2025

TABLE 104: Bladder Cancer Therapeutics Market in Russia by Treatment: A Historic Review in US$ Thousand for 2009-2017

TABLE 105: Russian Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 106: Rest of Europe Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025

TABLE 107: Bladder Cancer Therapeutics Market in Rest of Europe in US$ Thousand by Type: A Historic Review for the Period 2009-2017

TABLE 108: Rest of Europe Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 109: Rest of Europe Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018-2025

TABLE 110: Bladder Cancer Therapeutics Market in Rest of Europe in US$ Thousand by Treatment: A Historic Review for the Period 2009-2017

TABLE 111: Rest of Europe Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 112: Asia-Pacific Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025

TABLE 113: Bladder Cancer Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2009-2017

TABLE 114: Asia-Pacific Bladder Cancer Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025

TABLE 115: Bladder Cancer Therapeutics Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 116: Asia-Pacific Bladder Cancer Therapeutics Historic Market Scenario in US$ Thousand by Type: 2009-2017

TABLE 117: Asia-Pacific Bladder Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 118: Bladder Cancer Therapeutics Market in Asia-Pacific by Treatment: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 119: Asia-Pacific Bladder Cancer Therapeutics Historic Market Scenario in US$ Thousand by Treatment: 2009-2017

TABLE 120: Asia-Pacific Bladder Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025

AUSTRALIA

TABLE 121: Bladder Cancer Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025

TABLE 122: Australian Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Type: 2009-2017

TABLE 123: Australian Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 124: Bladder Cancer Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025

TABLE 125: Australian Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Treatment: 2009-2017

TABLE 126: Australian Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025

INDIA

TABLE 127: Indian Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025

TABLE 128: Indian Bladder Cancer Therapeutics Historic Market Review by Type in US$ Thousand: 2009-2017

TABLE 129: Bladder Cancer Therapeutics Market in India: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

TABLE 130: Indian Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018 to 2025

TABLE 131: Indian Bladder Cancer Therapeutics Historic Market Review by Treatment in US$ Thousand: 2009-2017

TABLE 132: Bladder Cancer Therapeutics Market in India: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025

SOUTH KOREA

TABLE 133: Bladder Cancer Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025

TABLE 134: South Korean Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Type: 2009-2017

TABLE 135: Bladder Cancer Therapeutics Market Share Distribution in South Korea by Type: 2009 VS 2019 VS 2025

TABLE 136: Bladder Cancer Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025

TABLE 137: South Korean Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Treatment: 2009-2017

TABLE 138: Bladder Cancer Therapeutics Market Share Distribution in South Korea by Treatment: 2009 VS 2019 VS 2025

REST OF ASIA-PACIFIC

TABLE 139: Rest of Asia-Pacific Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025

TABLE 140: Bladder Cancer Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017

TABLE 141: Rest of Asia-Pacific Bladder Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 142: Rest of Asia-Pacific Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Treatment for the Period 2018-2025

TABLE 143: Bladder Cancer Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Treatment for the Period 2009-2017

TABLE 144: Rest of Asia-Pacific Bladder Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025

LATIN AMERICA

TABLE 145: Latin American Bladder Cancer Therapeutics Market Trends by Region/Country in US$ Thousand: 2018-2025

TABLE 146: Bladder Cancer Therapeutics Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2009-2017

TABLE 147: Latin American Bladder Cancer Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025

TABLE 148: Latin American Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025

TABLE 149: Bladder Cancer Therapeutics Historic Market Analysis in Latin America in US$ Thousand by Type: 2009-2017

TABLE 150: Latin American Bladder Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 151: Latin American Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Treatment for the Period 2018-2025

TABLE 152: Bladder Cancer Therapeutics Historic Market Analysis in Latin America in US$ Thousand by Treatment: 2009-2017

TABLE 153: Latin American Bladder Cancer Therapeutics Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025

ARGENTINA

TABLE 154: Argentinean Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025

TABLE 155: Bladder Cancer Therapeutics Market in Argentina in US$ Thousand by Type: A Historic Review for the Period 2009-2017

TABLE 156: Argentinean Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 157: Argentinean Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018-2025

TABLE 158: Bladder Cancer Therapeutics Market in Argentina in US$ Thousand by Treatment: A Historic Review for the Period 2009-2017

TABLE 159: Argentinean Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025

BRAZIL

TABLE 160: Bladder Cancer Therapeutics Market in Brazil by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 161: Brazilian Bladder Cancer Therapeutics Historic Market Scenario in US$ Thousand by Type: 2009-2017

TABLE 162: Brazilian Bladder Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 163: Bladder Cancer Therapeutics Market in Brazil by Treatment: Estimates and Projections in US$ Thousand for the Period 2018-2025

TABLE 164: Brazilian Bladder Cancer Therapeutics Historic Market Scenario in US$ Thousand by Treatment: 2009-2017

TABLE 165: Brazilian Bladder Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025

MEXICO

TABLE 166: Bladder Cancer Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025

TABLE 167: Mexican Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Type: 2009-2017

TABLE 168: Mexican Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 169: Bladder Cancer Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025

TABLE 170: Mexican Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Treatment: 2009-2017

TABLE 171: Mexican Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025

REST OF LATIN AMERICA

TABLE 172: Rest of Latin America Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Type: 2018 to 2025

TABLE 173: Bladder Cancer Therapeutics Market in Rest of Latin America by Type: A Historic Review in US$ Thousand for 2009-2017

TABLE 174: Rest of Latin America Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 175: Rest of Latin America Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Treatment: 2018 to 2025

TABLE 176: Bladder Cancer Therapeutics Market in Rest of Latin America by Treatment: A Historic Review in US$ Thousand for 2009-2017

TABLE 177: Rest of Latin America Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025

MIDDLE EAST

TABLE 178: The Middle East Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025

TABLE 179: Bladder Cancer Therapeutics Market in the Middle East by Region/Country in US$ Thousand: 2009-2017

TABLE 180: The Middle East Bladder Cancer Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025

TABLE 181: The Middle East Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025

TABLE 182: The Middle East Bladder Cancer Therapeutics Historic Market by Type in US$ Thousand: 2009-2017

TABLE 183: Bladder Cancer Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

TABLE 184: The Middle East Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018 to 2025

TABLE 185: The Middle East Bladder Cancer Therapeutics Historic Market by Treatment in US$ Thousand: 2009-2017

TABLE 186: Bladder Cancer Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025

IRAN

TABLE 187: Iranian Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025

TABLE 188: Bladder Cancer Therapeutics Market in Iran: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017

TABLE 189: Iranian Bladder Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 190: Iranian Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Treatment for the Period 2018-2025

TABLE 191: Bladder Cancer Therapeutics Market in Iran: Historic Sales Analysis in US$ Thousand by Treatment for the Period 2009-2017

TABLE 192: Iranian Bladder Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025

ISRAEL

TABLE 193: Israeli Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025

TABLE 194: Bladder Cancer Therapeutics Market in Israel in US$ Thousand by Type: A Historic Review for the Period 2009-2017

TABLE 195: Israeli Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 196: Israeli Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018-2025

TABLE 197: Bladder Cancer Therapeutics Market in Israel in US$ Thousand by Treatment: A Historic Review for the Period 2009-2017

TABLE 198: Israeli Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025

SAUDI ARABIA

TABLE 199: Saudi Arabian Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025

TABLE 200: Bladder Cancer Therapeutics Historic Market Analysis in Saudi Arabia in US$ Thousand by Type: 2009-2017

TABLE 201: Saudi Arabian Bladder Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 202: Saudi Arabian Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Treatment for the Period 2018-2025

TABLE 203: Bladder Cancer Therapeutics Historic Market Analysis in Saudi Arabia in US$ Thousand by Treatment: 2009-2017

TABLE 204: Saudi Arabian Bladder Cancer Therapeutics Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED ARAB EMIRATES

TABLE 205: Bladder Cancer Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025

TABLE 206: United Arab Emirates Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Type: 2009-2017

TABLE 207: Bladder Cancer Therapeutics Market Share Distribution in United Arab Emirates by Type: 2009 VS 2019 VS 2025

TABLE 208: Bladder Cancer Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025

TABLE 209: United Arab Emirates Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Treatment: 2009-2017

TABLE 210: Bladder Cancer Therapeutics Market Share Distribution in United Arab Emirates by Treatment: 2009 VS 2019 VS 2025

REST OF MIDDLE EAST

TABLE 211: Bladder Cancer Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025

TABLE 212: Rest of Middle East Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Type: 2009-2017

TABLE 213: Rest of Middle East Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 214: Bladder Cancer Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025

TABLE 215: Rest of Middle East Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Treatment: 2009-2017

TABLE 216: Rest of Middle East Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025

AFRICA

TABLE 217: African Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Type: 2018 to 2025

TABLE 218: Bladder Cancer Therapeutics Market in Africa by Type: A Historic Review in US$ Thousand for 2009-2017

TABLE 219: African Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 220: African Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Treatment: 2018 to 2025

TABLE 221: Bladder Cancer Therapeutics Market in Africa by Treatment: A Historic Review in US$ Thousand for 2009-2017

TABLE 222: African Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025

IV. COMPETITION

ASTRAZENECA PLC

BRISTOL-MYERS SQUIBB COMPANY

CELGENE CORPORATION

ELI LILLY AND COMPANY

F. HOFFMANN-LA ROCHE AG

GLAXOSMITHKLINE PLC

NOVARTIS INTERNATIONAL AG

PFIZER

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Astrazeneca Plc
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ag
  • Glaxosmithkline Plc
  • Novartis International Ag
  • Pfizer
Note: Product cover images may vary from those shown
Adroll
adroll